These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24340675)

  • 1. [Dormancy of tumor cells].
    Strien L; Joensuu K; Heikkilä P
    Duodecim; 2013; 129(21):2245-52. PubMed ID: 24340675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor dormancy and cancer stem cells: two sides of the same coin?
    Kleffel S; Schatton T
    Adv Exp Med Biol; 2013; 734():145-79. PubMed ID: 23143979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-mediated dormancy: an equilibrium with cancer.
    Teng MW; Swann JB; Koebel CM; Schreiber RD; Smyth MJ
    J Leukoc Biol; 2008 Oct; 84(4):988-93. PubMed ID: 18515327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor dormancy of primary and secondary cancers.
    Udagawa T
    APMIS; 2008; 116(7-8):615-28. PubMed ID: 18834406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive cells in tumor immune escape and metastasis.
    Liu Y; Cao X
    J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte/macrophage infiltration in tumors: modulators of angiogenesis.
    Dirkx AE; Oude Egbrink MG; Wagstaff J; Griffioen AW
    J Leukoc Biol; 2006 Dec; 80(6):1183-96. PubMed ID: 16997855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Intercellular Communication in the Bone Microenvironment to Prevent Disseminated Tumor Cell Escape from Dormancy and Bone Metastatic Tumor Growth.
    Kreps LM; Addison CL
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-immune dynamics regulated in the microenvironment inform the transient nature of immune-induced tumor dormancy.
    Wilkie KP; Hahnfeldt P
    Cancer Res; 2013 Jun; 73(12):3534-44. PubMed ID: 23536560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does metronomic chemotherapy induce tumor angiogenic dormancy? A review of available preclinical and clinical data.
    Natale G; Bocci G
    Cancer Lett; 2018 Sep; 432():28-37. PubMed ID: 29885517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How do tumors actively escape from host immunosurveillance?
    Wilczyński JR; Duechler M
    Arch Immunol Ther Exp (Warsz); 2010 Dec; 58(6):435-48. PubMed ID: 20922572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms underlying tumor dormancy.
    Almog N
    Cancer Lett; 2010 Aug; 294(2):139-46. PubMed ID: 20363069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-vascular interactions and tumor dormancy.
    Naumov GN; Folkman J; Straume O; Akslen LA
    APMIS; 2008; 116(7-8):569-85. PubMed ID: 18834403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
    Shojaei F; Ferrara N
    Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression in the tumor microenvironment: where are we standing?
    Umansky V
    Semin Cancer Biol; 2012 Aug; 22(4):273-4. PubMed ID: 22709654
    [No Abstract]   [Full Text] [Related]  

  • 16. Consensus micro RNAs governing the switch of dormant tumors to the fast-growing angiogenic phenotype.
    Almog N; Ma L; Schwager C; Brinkmann BG; Beheshti A; Vajkoczy P; Folkman J; Hlatky L; Abdollahi A
    PLoS One; 2012; 7(8):e44001. PubMed ID: 22952847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor microenvironment: a mechanical force link.
    Huang B
    Sci China Life Sci; 2015 Feb; 58(2):202-4. PubMed ID: 25563980
    [No Abstract]   [Full Text] [Related]  

  • 18. Cancer dormancy: a model of early dissemination and late cancer recurrence.
    Páez D; Labonte MJ; Bohanes P; Zhang W; Benhanim L; Ning Y; Wakatsuki T; Loupakis F; Lenz HJ
    Clin Cancer Res; 2012 Feb; 18(3):645-53. PubMed ID: 22156560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular interactions in the vascular niche: implications in the regulation of tumor dormancy.
    Favaro E; Amadori A; Indraccolo S
    APMIS; 2008; 116(7-8):648-59. PubMed ID: 18834409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs and tumor vasculature normalization: impact on anti-tumor immune response.
    Matejuk A; Collet G; Nadim M; Grillon C; Kieda C
    Arch Immunol Ther Exp (Warsz); 2013 Aug; 61(4):285-99. PubMed ID: 23575964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.